Last Updated: May 10, 2026

List of Excipients in API human cord blood hematopoietic progenitor cell

✉ Email this page to a colleague

« Back to Dashboard

Excipients in ANDA-approved (generic) drugs containing human cord blood hematopoietic progenitor cell

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC	Excipient
University of Texas MD Anderson Cancer Center	human cord blood hematopoietic progenitor cell		DEXTRAN 40
University of Texas MD Anderson Cancer Center	human cord blood hematopoietic progenitor cell		DIMETHYL SULFOXIDE
University of Texas MD Anderson Cancer Center	human cord blood hematopoietic progenitor cell		HETASTARCH
University of Texas MD Anderson Cancer Center	human cord blood hematopoietic progenitor cell		HYDROXYETHYL STARCH 130/0.4
University of Texas MD Anderson Cancer Center	human cord blood hematopoietic progenitor cell		SODIUM CHLORIDE
>Company	>Ingredient	>NDC	>Excipient

Detailed excipient profiles for human cord blood hematopoietic progenitor cell

Excipient focus: DEXTRAN 40

human cord blood hematopoietic progenitor cell drug variants containing DEXTRAN 40

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
University of Texas MD Anderson Cancer Center	human cord blood hematopoietic progenitor cell
>Company	>Ingredient	>NDC

human cord blood hematopoietic progenitor cell drug variants not containing DEXTRAN 40

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
New York Blood Center	human cord blood hematopoietic progenitor cell	76489-001
>Company	>Ingredient	>NDC

Excipient focus: DIMETHYL SULFOXIDE

human cord blood hematopoietic progenitor cell drug variants containing DIMETHYL SULFOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
University of Texas MD Anderson Cancer Center	human cord blood hematopoietic progenitor cell
New York Blood Center	human cord blood hematopoietic progenitor cell	76489-001
>Company	>Ingredient	>NDC

human cord blood hematopoietic progenitor cell drug variants not containing DIMETHYL SULFOXIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: HETASTARCH

human cord blood hematopoietic progenitor cell drug variants containing HETASTARCH

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
University of Texas MD Anderson Cancer Center	human cord blood hematopoietic progenitor cell
>Company	>Ingredient	>NDC

human cord blood hematopoietic progenitor cell drug variants not containing HETASTARCH

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
New York Blood Center	human cord blood hematopoietic progenitor cell	76489-001
>Company	>Ingredient	>NDC

Excipient focus: HYDROXYETHYL STARCH 130/0.4

human cord blood hematopoietic progenitor cell drug variants containing HYDROXYETHYL STARCH 130/0.4

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
University of Texas MD Anderson Cancer Center	human cord blood hematopoietic progenitor cell
>Company	>Ingredient	>NDC

human cord blood hematopoietic progenitor cell drug variants not containing HYDROXYETHYL STARCH 130/0.4

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
New York Blood Center	human cord blood hematopoietic progenitor cell	76489-001
>Company	>Ingredient	>NDC

Excipient focus: SODIUM CHLORIDE

human cord blood hematopoietic progenitor cell drug variants containing SODIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
University of Texas MD Anderson Cancer Center	human cord blood hematopoietic progenitor cell
>Company	>Ingredient	>NDC

human cord blood hematopoietic progenitor cell drug variants not containing SODIUM CHLORIDE

Subscribe to access the full database, or Start Trial
Company	Ingredient	NDC
New York Blood Center	human cord blood hematopoietic progenitor cell	76489-001
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.